Literature DB >> 25771415

Intensity-modulated radiotherapy, not 3 dimensional conformal, is the preferred technique for treating locally advanced lung cancer.

Joe Y Chang1.   

Abstract

When used to treat lung cancer, intensity-modulated radiotherapy (IMRT) can deliver higher dose to the targets and spare more critical organs in lung cancer than can 3-dimensional conformal radiotherapy. However, tumor-motion management and optimized radiotherapy planning based on 4-dimensional computed tomography scanning are crucial to maximize the benefit of IMRT and to eliminate or minimize potential uncertainties. This article summarizes these strategies and reviews published findings supporting the safety and efficacy of IMRT for lung cancer.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2014        PMID: 25771415      PMCID: PMC4363100          DOI: 10.1016/j.semradonc.2014.11.002

Source DB:  PubMed          Journal:  Semin Radiat Oncol        ISSN: 1053-4296            Impact factor:   5.934


  29 in total

1.  A methodology for automatic intensity-modulated radiation treatment planning for lung cancer.

Authors:  Xiaodong Zhang; Xiaoqiang Li; Enzhuo M Quan; Xiaoning Pan; Yupeng Li
Journal:  Phys Med Biol       Date:  2011-06-08       Impact factor: 3.609

2.  Proton stereotactic body radiation therapy for clinically challenging cases of centrally and superiorly located stage I non-small-cell lung cancer.

Authors:  Steven P Register; Xiaodong Zhang; Radhe Mohan; Joe Y Chang
Journal:  Int J Radiat Oncol Biol Phys       Date:  2010-07-07       Impact factor: 7.038

3.  Intensity-modulated proton therapy reduces the dose to normal tissue compared with intensity-modulated radiation therapy or passive scattering proton therapy and enables individualized radical radiotherapy for extensive stage IIIB non-small-cell lung cancer: a virtual clinical study.

Authors:  Xiaodong Zhang; Yupeng Li; Xiaoning Pan; Li Xiaoqiang; Radhe Mohan; Ritsuko Komaki; James D Cox; Joe Y Chang
Journal:  Int J Radiat Oncol Biol Phys       Date:  2009-08-05       Impact factor: 7.038

Review 4.  Intensity modulating and other radiation therapy devices for dose painting.

Authors:  James M Galvin; Wilfried De Neve
Journal:  J Clin Oncol       Date:  2007-03-10       Impact factor: 44.544

5.  Initial evaluation of treatment-related pneumonitis in advanced-stage non-small-cell lung cancer patients treated with concurrent chemotherapy and intensity-modulated radiotherapy.

Authors:  Sue S Yom; Zhongxing Liao; H Helen Liu; Susan L Tucker; Chao-Su Hu; Xiong Wei; Xuanming Wang; Shulian Wang; Radhe Mohan; James D Cox; Ritsuko Komaki
Journal:  Int J Radiat Oncol Biol Phys       Date:  2007-02-22       Impact factor: 7.038

6.  Automated volumetric modulated Arc therapy treatment planning for stage III lung cancer: how does it compare with intensity-modulated radio therapy?

Authors:  Enzhuo M Quan; Joe Y Chang; Zhongxing Liao; Tingyi Xia; Zhiyong Yuan; Hui Liu; Xiaoqiang Li; Cody A Wages; Radhe Mohan; Xiaodong Zhang
Journal:  Int J Radiat Oncol Biol Phys       Date:  2012-09-01       Impact factor: 7.038

7.  Feasibility of sparing lung and other thoracic structures with intensity-modulated radiotherapy for non-small-cell lung cancer.

Authors:  H Helen Liu; Xiaochun Wang; Lei Dong; Qiuwen Wu; Zhongxing Liao; Craig W Stevens; Thomas M Guerrero; Ritsuko Komaki; James D Cox; Radhe Mohan
Journal:  Int J Radiat Oncol Biol Phys       Date:  2004-03-15       Impact factor: 7.038

8.  A population-based comparative effectiveness study of radiation therapy techniques in stage III non-small cell lung cancer.

Authors:  Jeremy P Harris; James D Murphy; Alexandra L Hanlon; Quynh-Thu Le; Billy W Loo; Maximilian Diehn
Journal:  Int J Radiat Oncol Biol Phys       Date:  2014-02-01       Impact factor: 7.038

9.  Four-dimensional IMRT treatment planning using a DMLC motion-tracking algorithm.

Authors:  Yelin Suh; Amit Sawant; Raghu Venkat; Paul J Keall
Journal:  Phys Med Biol       Date:  2009-05-28       Impact factor: 3.609

Review 10.  Image-guided radiation therapy for non-small cell lung cancer.

Authors:  Joe Y Chang; Lei Dong; Helen Liu; George Starkschall; Peter Balter; Radhe Mohan; Zhongxing Liao; James D Cox; Ritsuko Komaki
Journal:  J Thorac Oncol       Date:  2008-02       Impact factor: 15.609

View more
  9 in total

1.  Proton Beam Radiotherapy and Concurrent Chemotherapy for Unresectable Stage III Non-Small Cell Lung Cancer: Final Results of a Phase 2 Study.

Authors:  Joe Y Chang; Vivek Verma; Ming Li; Wencheng Zhang; Ritsuko Komaki; Charles Lu; Pamela K Allen; Zhongxing Liao; James Welsh; Steven H Lin; Daniel Gomez; Melenda Jeter; Michael O'Reilly; Ronald X Zhu; Xiaodong Zhang; Heng Li; Radhe Mohan; John V Heymach; Ara A Vaporciyan; Stephen Hahn; James D Cox
Journal:  JAMA Oncol       Date:  2017-08-10       Impact factor: 31.777

2.  Intensity-Modulated Radiation Therapy May Improve Local-Regional Tumor Control for Locally Advanced Non-Small Cell Lung Cancer Compared With Three-Dimensional Conformal Radiation Therapy.

Authors:  Jingbo Wang; Zongmei Zhou; Jun Liang; Qinfu Feng; Zefen Xiao; Zhouguang Hui; Xiaozhen Wang; Jima Lv; Dongfu Chen; Hongxing Zhang; Zhe Ji; Jianzhong Cao; Lipin Liu; Wei Jiang; Yu Men; Cai Xu; Jiangrong Dai; Weibo Yin; Luhua Wang
Journal:  Oncologist       Date:  2016-09-14

Review 3.  Advanced radiation techniques for locally advanced non-small cell lung cancer: intensity-modulated radiation therapy and proton therapy.

Authors:  Nikhil Yegya-Raman; Wei Zou; Ke Nie; Jyoti Malhotra; Salma K Jabbour
Journal:  J Thorac Dis       Date:  2018-08       Impact factor: 2.895

4.  Comparative effectiveness of intensity modulated radiation therapy to 3-dimensional conformal radiation in locally advanced lung cancer: pathological and clinical outcomes.

Authors:  Sarit Appel; Jair Bar; Alon Ben-Nun; Marina Perelman; Dror Alezra; Damien Urban; Maoz Ben-Ayun; Nir Honig; Efrat Ofek; Tamar Katzman; Amir Onn; Sumit Chatterji; Sergey Dubinski; Lev Tsvang; Shira Felder; Judith Kraitman; Ory Haisraely; Tatiana Rabin Alezra; Sivan Lieberman; Edith M Marom; Nir Golan; David Simansky; Zvi Symon; Yaacov Richard Lawrence
Journal:  Br J Radiol       Date:  2019-04-01       Impact factor: 3.039

5.  Multi-institutional evaluation using the end-to-end test for implementation of dynamic techniques of radiation therapy in Thailand.

Authors:  Lalida Tuntipumiamorn; Puangpen Tangboonduangjit; Taweap Sanghangthum; Rattapol Rangseevijitprapa; Chirasak Khamfongkhruea; Thida Niyomthai; Boonrut Vuttiprasertpong; Supranee Supanant; Nongnuch Chatchaipaiboon; Porntip Iampongpaiboon; Pitchayut Nakkrasae; Tanwiwat Jaikuna
Journal:  Rep Pract Oncol Radiother       Date:  2018-11-28

6.  Intensity-modulated versus 3-dimensional conformal radiotherapy in the definitive treatment of esophageal cancer: comparison of outcomes and acute toxicity.

Authors:  Matthias Felix Haefner; Kristin Lang; Vivek Verma; Stefan Alexander Koerber; Lorenz Uhlmann; Juergen Debus; Florian Sterzing
Journal:  Radiat Oncol       Date:  2017-08-15       Impact factor: 3.481

7.  Efficacy of postoperative radiotherapy in patients with pathological stage N2 epidermal growth factor receptor wild type adenocarcinoma and squamous cell carcinoma lung cancer.

Authors:  Yen-Kuang Lin; Han-Lin Hsu; Wei-Cheng Lin; Jer-Hwa Chang; Yw-Chun Chang; Chia-Lun Chang; Kevin Sheng-Po Yuan; Alexander T H Wu; Szu-Yuan Wu
Journal:  Oncotarget       Date:  2017-05-23

8.  Research Value of Intensity Modulated Radiation Therapy in Alleviating Parotid Gland Function Injury in Patients with Stage N0 Nasopharyngeal Carcinoma from Physical and Dosimetric Aspects.

Authors:  Lirong Zheng; Hong Wang; Neng Yang; Fenglei Du; Lin Xiao; Gangfeng Wu
Journal:  Comput Math Methods Med       Date:  2022-07-11       Impact factor: 2.809

9.  Image-guidance triggered adaptive replanning of radiation therapy for locally advanced lung cancer: an evaluation of cases requiring plan adaptation.

Authors:  Sarit Appel; Jair Bar; Dror Alezra; Maoz Ben-Ayun; Tatiana Rabin-Alezra; Nir Honig; Tamar Katzman; Sumit Chatterji; Zvi Symon; Yaacov Richard Lawrence
Journal:  Br J Radiol       Date:  2019-11-13       Impact factor: 3.039

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.